Although the data still needs to be scrutinized, Quebec company Medicago says its latest trial suggests the COVID-19 vaccine it’s produced with GlaxoSmithKline is showing promise. Jamie Mauracher explains where the Canadian-made shot is now in the approval process, and its implications beyond this country.
Global National
Canadian manufacturer Medicago says its COVID-19 vaccine shows promise in trials
More Videos
-
Pro-Palestinian campus protests spark historic comparisons to anti-Vietnam war movement
-
Reality check on Canada’s efforts to curb carbon emissions
-
Ontario chemical plant ordered to shut down
-
Gaza crisis: Hamas weighs response to ceasefire proposal
-
Campus protests: Hundreds arrested as UCLA encampment dismantled
-
McGill encampment: Demonstrators confronted by counter-protest
You are viewing an Accelerated Mobile Webpage.
View Original Article